Ceramide (d18:1/24:0) (Compound)

Go to Compound classification

ID	2509
Name	Ceramide (d18:1/24:0)
Synonyms	Cer(d18:1/24:0); N-Lignoceroyl-D-erythro-sphingosine; N-Tetracosanoylsphingosine; N-Lignoceroylsphingosine
Structure	MOL SDF PDB SMILES InChI Structure for EE002509 (Ceramide (d18:1/24:0)) 3D Structure for EE002509 (Ceramide (d18:1/24:0)) Cer(d18:1/24:0) Mrv1652306122021152D 47 46 0 0 0 0 999 V2000 -2.3824 0.3590 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.6679 0.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9699 -0.3554 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.7950 -0.3554 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9590 0.3595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.0969 0.7716 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -3.0969 1.5430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.8110 0.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5251 0.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.2392 0.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9534 0.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.6675 0.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.3816 0.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -8.0957 0.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -8.8099 0.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -9.5240 0.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.2381 0.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.9522 0.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -11.6664 0.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -12.3805 0.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -13.0946 0.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -13.8087 0.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5095 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5095 -1.5393 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.2236 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9377 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.6518 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.3660 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.0801 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.7942 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -8.5083 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -9.2225 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -9.9366 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.6507 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -11.3648 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -12.0790 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -12.7931 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -13.5072 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -14.2213 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -14.9355 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -15.6496 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -16.3637 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -17.0778 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -17.7919 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -18.5060 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -19.2201 -0.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -19.9343 -0.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 1 3 1 1 0 0 0 1 4 1 6 0 0 0 5 2 1 0 0 0 0 4 23 1 0 0 0 0 1 6 1 0 0 0 0 6 7 1 1 0 0 0 6 8 1 0 0 0 0 8 9 2 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 18 19 1 0 0 0 0 19 20 1 0 0 0 0 20 21 1 0 0 0 0 21 22 1 0 0 0 0 23 24 2 0 0 0 0 23 25 1 0 0 0 0 25 26 1 0 0 0 0 26 27 1 0 0 0 0 27 28 1 0 0 0 0 28 29 1 0 0 0 0 29 30 1 0 0 0 0 30 31 1 0 0 0 0 31 32 1 0 0 0 0 32 33 1 0 0 0 0 33 34 1 0 0 0 0 34 35 1 0 0 0 0 35 36 1 0 0 0 0 36 37 1 0 0 0 0 37 38 1 0 0 0 0 38 39 1 0 0 0 0 39 40 1 0 0 0 0 40 41 1 0 0 0 0 41 42 1 0 0 0 0 42 43 1 0 0 0 0 43 44 1 0 0 0 0 44 45 1 0 0 0 0 45 46 1 0 0 0 0 46 47 1 0 0 0 0 M END > <DATABASE_ID> EE002509 > <DATABASE_NAME> ExposomeExplorer > <SMILES> [H][C@@](CO)(NC(=O)CCCCCCCCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC > <INCHI_IDENTIFIER> InChI=1S/C42H83NO3/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-42(46)43-40(39-44)41(45)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2/h35,37,40-41,44-45H,3-34,36,38-39H2,1-2H3,(H,43,46)/b37-35+/t40-,41+/m0/s1 > <INCHI_KEY> ZJVVOYPTFQEGPH-AUTSUKAISA-N > <FORMULA> C42H83NO3 > <MOLECULAR_WEIGHT> 650.1133 > <EXACT_MASS> 649.637295527 > <JCHEM_ACCEPTOR_COUNT> 3 > <JCHEM_ATOM_COUNT> 129 > <JCHEM_AVERAGE_POLARIZABILITY> 90.3194776956361 > <JCHEM_BIOAVAILABILITY> 0 > <JCHEM_DONOR_COUNT> 3 > <JCHEM_FORMAL_CHARGE> 0 > <JCHEM_GHOSE_FILTER> 0 > <JCHEM_IUPAC> N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tetracosanamide > <ALOGPS_LOGP> 10.35 > <JCHEM_LOGP> 14.421904463666667 > <ALOGPS_LOGS> -7.46 > <JCHEM_MDDR_LIKE_RULE> 0 > <JCHEM_NUMBER_OF_RINGS> 0 > <JCHEM_PHYSIOLOGICAL_CHARGE> 0 > <JCHEM_PKA> 14.235174526465968 > <JCHEM_PKA_STRONGEST_ACIDIC> 13.61974905944669 > <JCHEM_PKA_STRONGEST_BASIC> -1.0489347908069546 > <JCHEM_POLAR_SURFACE_AREA> 69.56 > <JCHEM_REFRACTIVITY> 202.58369999999996 > <JCHEM_ROTATABLE_BOND_COUNT> 38 > <JCHEM_RULE_OF_FIVE> 0 > <ALOGPS_SOLUBILITY> 2.25e-05 g/l > <JCHEM_TRADITIONAL_IUPAC> C24 cer > <JCHEM_VEBER_RULE> 0 $$$$
Description
Classification	Compounds > Chemical entities > Organic compounds > Lipids and lipid-like molecules > Sphingolipids > Ceramides
CAS number
PubChem ID	5283571
ChEBI ID	72965
FooDB ID	FDB023543
HMDB ID	HMDB0004956

Chemical data

MolDBi data

IUPAC Name	N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tetracosanamide
Traditional IUPAC Name	C24 cer
Formula	C42H83NO3
InChI	InChI=1S/C42H83NO3/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-42(46)43-40(39-44)41(45)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2/h35,37,40-41,44-45H,3-34,36,38-39H2,1-2H3,(H,43,46)/b37-35+/t40-,41+/m0/s1
InChI Key	ZJVVOYPTFQEGPH-AUTSUKAISA-N
Molecular weight	650.1133
Exact mass	649.637295527
SMILES	[H][C@@](CO)(NC(=O)CCCCCCCCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC

ClassyFire Taxonomy

Description	belongs to the class of organic compounds known as ceramides. These are lipid molecules containing a sphingosine in which the amine group is linked to a fatty acid.
Kingdom	Organic compounds
Super Class	Lipids and lipid-like molecules
Class	Sphingolipids
Sub Class	Ceramides
Direct Parent	Ceramides
Alternative Parents	N-acyl amines Secondary carboxylic acid amides Secondary alcohols Primary alcohols Organopnictogen compounds Organonitrogen compounds Organic oxides Hydrocarbon derivatives Carbonyl compounds

Publications with Ceramide (d18:1/24:0)

ID	Title	First author	Authors	Year	Journal	Volume	Issue	Pages	PubMed ID	DOI	Study design	No. of Biomarkers	No. of Intake values	No. of Concentration values	No. of Reproducibility values	No. of Correlation values	No. of Metabolomic associations	No. of Microbiota associations	No. of Cancer associations

Biomarker data

Measurements of Ceramide (d18:1/24:0) in biospecimens

Concentration values

ID	Parent ID	Depth	Subject group	Population	Country	Cohort	Biomarker Time definition	Biospecimen	Analytical method	Biomarker	Biomarker detail	Measurement size	Detected (nb)	Detected (%)	Detected only?	Arithmethic mean	Arithmethic SD	Geometric mean	Geometric SD	Min	Min (detected)	Percentile_05	Percentile_10	Percentile_25	Median	Percentile_75	Percentile_90	Percentile_95	Max	Interquartile range	Mean 95% CI lower	Mean 95% CI upper	GMean 95% CI lower	GMean 95% CI upper	Unit	Converted arithmetic mean	Converted geometric mean	Converted median	Converted unit	Adjustment type	Adjusted on	Regressed on	Expressed as	Publication

Reproducibility values

ID	Excretion ID	Subject group	Population	Country	Cohort	Biomarker Time definition	Biospecimen	Analytical method	Biomarker	Biomarker detail	Arithmetic mean	Geometric mean	Median	Unit	Adjusted on	Reproducibility size	ICC	ICC 95% CI lower	ICC 95% CI upper	CV% WS	CV% BS	VAR WS	VAR BS	Publication

Associations of Ceramide (d18:1/24:0) with exposures

Correlation values

ID	Intake ID	Excretion ID	Subject group	Population	Country	Cohort	Intake Time definition	Intake Assessment method	Intake	Intake detail	Supplement intakes included?	Intake Arithmetic mean	Intake Geometric mean	Intake Median	Intake Unit	Intake Adjusted on	Biomarker Time definition	Biospecimen	Analytical method	Biomarker	Biomarker detail	Biomarker Arithmetic mean	Biomarker Geometric mean	Biomarker Median	Biomarker Unit	Biomarker Adjusted on	Correlation size	Correlation type	Correlation value	Correlation 95% CI lower	Correlation 95% CI upper	Correlation p-value	Significant?	Measurement adjustment	Deattenuated?	Covariates	Publication

Metabolomic associations

ID	Intake ID	Excretion ID	Subject group	Population	Country	Cohort	No. of subjects	Intake Assessment method	Intake	Intervention dose	Biospecimen	Analytical method	Biomarker	Structural identification	Feature selection	Area under curve	Sensitivity	Specificity	PLS-DA VIP	Beta coefficient	Beta coefficient p-value	ANOVA p-value	Publication

Microbiota associations

ID	Biomarker	Experimental evidence	Organism	Biospecimen	Antibiotic	Bacterial source	Substrate	Publication

Associations of Ceramide (d18:1/24:0) with cancer risk

Cancer associations

ID	Excretion ID	Subject group	Population	Country	Cohort	No. of subjects	No. of cases	No. of controls	Biospecimen	Analytical method	Biomarker	Biomarker detail	Cancer	Study design	Publication

Exposure data

Measurements of Ceramide (d18:1/24:0) exposures in populations

Intake values

ID	Parent ID	Depth	Subject group	Population	Country	Cohort	Intake Time definition	Intake assessment tool	Intake food coverage	Intake time coverage	Intake Assessment method	Intake	Intake detail	Food description	Supplement intakes included?	Measurement size	Detected (nb)	Detected (%)	Detected only?	Arithmethic mean	Arithmethic SD	Geometric mean	Geometric SD	Min	Min (detected)	Percentile_05	Percentile_10	Percentile_25	Median	Percentile_75	Percentile_90	Percentile_95	Max	Interquartile range	Mean 95% CI lower	Mean 95% CI upper	GMean 95% CI lower	GMean 95% CI upper	Unit	Converted arithmetic mean	Converted geometric mean	Converted median	Converted unit	Adjustment type	Adjusted on	Regressed on	Expressed as	Publication

Associations of Ceramide (d18:1/24:0) exposures with biomarkers

Correlation values

ID	Intake ID	Excretion ID	Subject group	Population	Country	Cohort	Intake Time definition	Intake Assessment method	Intake	Intake detail	Supplement intakes included?	Intake Arithmetic mean	Intake Geometric mean	Intake Median	Intake Unit	Intake Adjusted on	Biomarker Time definition	Biospecimen	Analytical method	Biomarker	Biomarker detail	Biomarker Arithmetic mean	Biomarker Geometric mean	Biomarker Median	Biomarker Unit	Biomarker Adjusted on	Correlation size	Correlation type	Correlation value	Correlation 95% CI lower	Correlation 95% CI upper	Correlation p-value	Significant?	Measurement adjustment	Deattenuated?	Covariates	Publication